News Scotland's NHS to fund Ipsen cancer diarrhoea drug Decision welcomed as step forward for patients
Partner Content Partner Content Official Agenda released for 8th annual Orphan Drugs and Rar... Agenda released for 8th Orphan Drugs and Rare Diseases
News US lawmakers back 'right to try' legislation US lawmakers have approved new laws giving terminally ill patients the “right to try” unapproved drugs if there are no alternatives.
News Spark/Pfizer eye phase 3 trial of haemophilia B gene therapy Spark Therapeutics has already revolutionised treatment of a rare hereditary eye disease with a gene therapy, but could it be about to do the same with haemophilia B?
News Roche haemophilia data piles pressure on Shire Hemlibra threatens to take market share from Advate
Partner Content Partner Content OPEN Health invest in rare disease OPEN Health invest in rare disease
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
